INFLUENCE OF 1-(ALKYLAMINO)SILATRANES AND ISONIAZID ON THE ANTITUMOR-ACTIVITY OF CYCLOPHOSPHAMIDE IN MICE BEARING SA 180 TUMORS

被引：5
|
作者：
KOZLOWSKI, H
RADECKI, A
LUKASIAK, J
HRABOWSKA, M
机构：
[1] MED ACAD GDANSK,INST OBSTET & GYNECOL,DEPT PATHOL,UL KLIN,PL-80402 GDANSK,POLAND
[2] MED ACAD GDANSK,DEPT PHYS CHEM,PL-80402 GDANSK,POLAND
[3] MED ACAD GDANSK,INSTRUMENTAL METHODS LAB,PL-80402 GDANSK,POLAND
[4] MED ACAD GDANSK,INST CHEM & ANALYT,PL-80402 GDANSK,POLAND
来源：
EXPERIMENTAL PATHOLOGY | 1985年 / 28卷 / 04期
关键词：
D O I：
10.1016/S0232-1513(85)80011-6
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：215 / 223
页数：9
相关论文
共 14 条
  • [1] ANTITUMOR-ACTIVITY OF CYCLOPHOSPHAMIDE AND LIPOPOLYSACCHARIDE IN TUMOR-BEARING MICE PRETREATED WITH BCG
    SATO, H
    ITO, M
    ABE, T
    KUMANO, N
    MOTOMIYA, M
    KONNO, K
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 153 (02): : 151 - 160
  • [2] THE INFLUENCE OF CYCLOPHOSPHAMIDE ON ANTITUMOR IMMUNITY IN MICE BEARING LATE-STAGE TUMORS
    CULO, F
    KLAPAN, I
    KOLAK, T
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1993, 36 (02) : 115 - 122
  • [3] CORRELATION BETWEEN SERIC ANTITUMOR-ACTIVITY AND CONCOMITANT RESISTANCE IN MICE BEARING NONIMMUNOGENIC TUMORS
    RUGGIERO, RA
    BUSTUOABAD, OD
    CRAMER, P
    BONFIL, RD
    PASQUALINI, CD
    CANCER RESEARCH, 1990, 50 (22) : 7159 - 7165
  • [4] HOST-MEDIATED ANTITUMOR-ACTIVITY (HMAA) OF SMANCS, AN ANTITUMOR CHEMOTHERAPEUTIC AGENT,IN MICE BEARING SYNGENEIC SOLID TUMORS
    SUZUKI, F
    POLLARD, RB
    MAEDA, H
    ANTICANCER RESEARCH, 1988, 8 (05) : 1098 - 1098
  • [5] ANTITUMOR-ACTIVITY AND PHARMACOKINETICS OF LM985 AND LM975 IN MICE BEARING TRANSPLANTABLE COLON TUMORS
    DOUBLE, JA
    BIBBY, MC
    PHILLIPS, RM
    LOADMAN, PM
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 84 - 84
  • [6] ANTITUMOR-ACTIVITY OF ORALLY-ADMINISTERED SMANCS, A POLYMER-CONJUGATED PROTEIN DRUG, IN MICE BEARING VARIOUS MURINE TUMORS
    SCHMITT, DA
    KISANUKI, K
    KIMURA, S
    OKA, K
    POLLARD, RB
    MAEDA, H
    SUZUKI, F
    ANTICANCER RESEARCH, 1992, 12 (6B) : 2219 - 2224
  • [7] Combined antitumor effect of cyclophosphamide and bromodeoxyuridine in BDF1 mice bearing L1210 ascites tumors
    Kagawa, Yoshiyuki
    Noge, Ichiro
    Higashigawa, Masamune
    Komada, Yoshihiro
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (01) : 57 - 61
  • [8] COMBINATION THERAPY WITH THYMOSIN ALPHA-1 POTENTIATES THE ANTITUMOR-ACTIVITY OF INTERLEUKIN-2 WITH CYCLOPHOSPHAMIDE IN THE TREATMENT OF THE LEWIS LUNG-CARCINOMA IN MICE
    MASTINO, A
    FAVALLI, C
    GRELLI, S
    RASI, G
    PICA, F
    GOLDSTEIN, AL
    GARACI, E
    INTERNATIONAL JOURNAL OF CANCER, 1992, 50 (03) : 493 - 499
  • [9] ADJUVANT EFFECTS OF CALMODULIN ANTAGONISTS ON ANTITUMOR-ACTIVITY OF 1-(2-TETRAHYDROFURYL)-5-FLUOROURACIL (FTORAFUR) AND A MIXTURE OF FTORAFUR AND URACIL (UFT) IN NUDE-MICE BEARING HUMAN OVARIAN CARCINOMAS
    KIKUCHI, Y
    OOMORI, K
    IWANO, I
    KIZAWA, I
    MIYAUCHI, M
    KITA, T
    KUKI, E
    GYNECOLOGIC ONCOLOGY, 1989, 35 (02) : 172 - 176
  • [10] EFFECTS OF 3 IRREVERSIBLE INHIBITORS OF ORNITHINE DECARBOXYLASE ON MACROPHAGE-MEDIATED TUMORICIDAL ACTIVITY AND ANTITUMOR-ACTIVITY IN B16F1 TUMOR-BEARING MICE
    BOWLIN, TL
    HOEPER, BJ
    ROSENBERGER, AL
    DAVIS, GF
    SUNKARA, PS
    CANCER RESEARCH, 1990, 50 (15) : 4510 - 4514
12